METROPOLITAN LIFE INSURANCE CO/NY - SAGE THERAPEUTICS INC ownership

SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 247 filers reported holding SAGE THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 1.22 and the average weighting 0.2%.

Quarter-by-quarter ownership
METROPOLITAN LIFE INSURANCE CO/NY ownership history of SAGE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$62,337
-54.1%
3,029
+4.8%
0.00%
-57.1%
Q2 2023$135,935
+12.1%
2,8910.0%0.01%
+16.7%
Q1 2023$121,306
+1.0%
2,891
-8.2%
0.01%
+20.0%
Q4 2022$120,065
-2.6%
3,1480.0%0.01%
-16.7%
Q3 2022$123,276
+21.2%
3,1480.0%0.01%
+50.0%
Q2 2022$101,680
+133.4%
3,148
+207.4%
0.00%
+300.0%
Q4 2021$43,561
-3.7%
1,024
+0.3%
0.00%0.0%
Q3 2021$45,241
-25.0%
1,021
-3.9%
0.00%0.0%
Q2 2021$60,332
-34.7%
1,062
-13.9%
0.00%0.0%
Q1 2021$92,365
-11.7%
1,234
+2.1%
0.00%
-50.0%
Q4 2020$104,591
+37.6%
1,209
-2.8%
0.00%
+100.0%
Q3 2020$76,033
+44.7%
1,244
-1.6%
0.00%0.0%
Q2 2020$52,557
-48.9%
1,264
-64.7%
0.00%
-50.0%
Q1 2020$102,875
-61.4%
3,582
-3.1%
0.00%
-50.0%
Q4 2019$266,742
-48.8%
3,695
-0.5%
0.00%
-55.6%
Q3 2019$521,177
-20.6%
3,715
+3.6%
0.01%
-18.2%
Q2 2019$656,744
+12.5%
3,587
-2.3%
0.01%0.0%
Q1 2019$583,714
+74.3%
3,670
+5.0%
0.01%
+57.1%
Q4 2018$334,882
-32.4%
3,496
-0.3%
0.01%
-22.2%
Q3 2018$495,505
-99.9%
3,508
-1.9%
0.01%0.0%
Q2 2018$559,908,000
-73.4%
3,577
-72.6%
0.01%
-70.0%
Q1 2018$2,104,541,000
+108605.6%
13,066
+11.2%
0.03%
+15.4%
Q4 2017$1,936,000
+32.5%
11,752
-49.9%
0.03%
+188.9%
Q3 2017$1,461,000
-21.8%
23,4520.0%0.01%
-30.8%
Q2 2017$1,868,000
+23.1%
23,452
+9.9%
0.01%
+18.2%
Q1 2017$1,517,000
+39.2%
21,3400.0%0.01%
+37.5%
Q4 2016$1,090,000
+20.0%
21,340
+8.2%
0.01%
+14.3%
Q3 2016$908,000
+52.9%
19,7220.0%0.01%
+75.0%
Q2 2016$594,000
+53.5%
19,722
+63.3%
0.00%
+33.3%
Q1 2016$387,000
-31.9%
12,077
+24.0%
0.00%
-25.0%
Q4 2015$568,000
+37.9%
9,7420.0%0.00%
+33.3%
Q3 2015$412,000
-42.1%
9,7420.0%0.00%
-40.0%
Q2 2015$711,000
+315.8%
9,742
+108.7%
0.01%
+400.0%
Q4 2014$171,000
-34.5%
4,668
-43.6%
0.00%
-50.0%
Q3 2014$261,0008,2770.00%
Other shareholders
SAGE THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
RTW INVESTMENTS, LP 5,149,482$105,976,3402.24%
Palo Alto Investors LP 1,005,776$20,698,8701.96%
Boxer Capital, LLC 1,094,000$22,514,5201.20%
Bellevue Group AG 3,513,351$72,304,7641.16%
PDT Partners, LLC 181,625$3,737,8430.47%
EASTERLY INVESTMENT PARTNERS LLC 195,643$4,026,3330.44%
Harvest Investment Services, LLC 30,302$623,6150.40%
Simplify Asset Management Inc. 120,030$2,470,2170.28%
SAMLYN CAPITAL, LLC 739,867$15,226,4630.25%
CAXTON ASSOCIATES LP 68,035$1,400,1600.19%
View complete list of SAGE THERAPEUTICS INC shareholders